The new customers include Affibody AB, Beth Israel Deaconess Medical Center, The Biomedical Engineering Center at The Industrial Technology Research Institute of Taiwan R.O.C., Boystown National Research Hospital, Celgene Corporation, Cureon A/S, Evotec OAI, Ferring Research Institute Inc., GPC Biotech AG, ImClone Systems Incorporated, Immusol Inc., H. Lundbeck A/S, Neurogenetics Inc., ONO Pharmaceutical Co. Ltd., OSI Pharmaceuticals Inc., PPD Discovery, Hoffmann-La Roche Inc, University of Minnesota, University of Tokyo, Xenoport Inc, and an unnamed European pharmaceutical company.
This subscription to DoubleTwist.com(TM) will further stimulate our research opportunities. We anticipate that all of our research activities will be substantially benefited from using the DoubleTwist genomic information and bioinformatics analysis tools, said Dr Johnsee Lee, General Director of the Biomedical Engineering Center at the Industrial Technology Research Institute (ITRI).
We are excited about the momentum we are seeing with the adoption of our online solution, DoubleTwist.com, and our growing market leadership for online genomic research solutions, said Robert Williamson, president and COO, DoubleTwist, in a statement to the press.
